GOLDEN BIOTECHNOLOGY CORP financial statements, including revenue, expenses, profit, and loss
The total revenue of 4132 for the last semiannual is 22.95 M TWD, and it's 33.54% lower compared to the previous semiannual. The net income of H1 24 is -160.80 M TWD.